CAF-induced physical constraints controlling T cell state and localization in solid tumours

L Arpinati, G Carradori, R Scherz-Shouval - Nature Reviews Cancer, 2024 - nature.com
Solid tumours comprise cancer cells that engage in continuous interactions with non-
malignant cells and with acellular components, forming the tumour microenvironment (TME) …

ROS: A “booster” for chronic inflammation and tumor metastasis

A Chen, H Huang, S Fang, Q Hang - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Reactive oxygen species (ROS) are a group of highly active molecules produced by normal
cellular metabolism and play a crucial role in the human body. In recent years, researchers …

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

F Zhang, Y Ma, D Li, J Wei, K Chen, E Zhang… - Journal of Hematology & …, 2024 - Springer
Metabolic reprogramming provides tumors with an energy source and biofuel to support
their survival in the malignant microenvironment. Extensive research into the intrinsic …

Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational …

B Wang, Y Pan, Y **e, C Wang, Y Yang, H Sun… - Biological Procedures …, 2024 - Springer
Pancreatic cancer is a devastating malignancy with a high mortality rate, poor prognosis,
and limited treatment options. The tumor microenvironment (TME) plays a crucial role in …

Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression

N Dhungel, AM Dragoi - Frontiers in Molecular Biosciences, 2024 - frontiersin.org
The interaction between the tumor microenvironment (TME) and the cancer cells is a
complex and mutually beneficial system that leads to rapid cancer cells proliferation …

Clinical and translational implications of immunotherapy in sarcomas

F Recine, S Vanni, A Bongiovanni, V Fausti… - Frontiers in …, 2024 - frontiersin.org
Immunotherapy has emerged as promising treatment in sarcomas, but the high variability in
terms of histology, clinical behavior and response to treatments determines a particular …

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

K Huang, Y Han, Y Chen, H Shen, S Zeng, C Cai - Molecular Cancer, 2025 - Springer
Metabolic reprogramming within the tumor microenvironment (TME) is a hallmark of cancer
and a crucial determinant of tumor progression. Research indicates that various metabolic …

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

J Ge, X Yin, L Chen - Frontiers in Immunology, 2024 - frontiersin.org
Regulatory T cells (Tregs), a subset of CD4+ T cells marked by the expression of the
transcription factor forkhead box protein 3 (Foxp3), are pivotal in maintaining immune …

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

A Glaviano, HSH Lau, LM Carter, EHC Lee… - Journal of hematology & …, 2025 - Springer
The tumor microenvironment (TME) is integral to cancer progression, impacting metastasis
and treatment response. It consists of diverse cell types, extracellular matrix components …

Soft tissue sarcomas at the single-cell and spatial resolution: new markers and targets

ME Menyailo, EE Kopantseva, AA Khozyainova… - Cancer Gene …, 2024 - nature.com
Soft tissue sarcomas (STS) are heterogeneous and aggressive tumors, originating in
connective tissues embryologically derived from the mesenchyme. Due to their rarity, crucial …